K. Kemp

发表

Identification of Research Priorities for Inflammatory Bowel Disease Nursing in Europe: a Nurses-European Crohn’s and Colitis Organisation Delphi Survey

L. Dibley, W. Czuber-Dochan, L. Jelsness-Jørgensen, 2016, Journal of Crohn's & colitis.

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.

M. Ferrante, L. Peyrin-Biroulet, G. Fiorino, 2017, Journal of Crohn's & colitis.

Systematic review: advice lines for patients with inflammatory bowel disease

L. Moortgat, U. Chauhan, P. Bager, 2018, Scandinavian journal of gastroenterology.

Aligning oral mesalazine treatment to health service priorities: guidance for nurses

K. Kemp, Mark Sephton, 2013, Frontline Gastroenterology.

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

Philip Smith, C. Lees, N. Bhala, 2021, The Lancet Gastroenterology & Hepatology.

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.

C. Stansfield, C. Selinger, J. Limdi, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

OC-035 Streamlining immunosuppression therapy and improving the quality of care for ibd patients: a virtual immunosuppression clinic

S. Levison, K. Kemp, F. Birchall, 2017, Gut.

What Are the Top 10 Research Questions in the Treatment of Inflammatory Bowel Disease? A Priority Setting Partnership with the James Lind Alliance

J. Mclaughlin, O. Faiz, A. Hart, 2016, Journal of Crohn's & colitis.

P483 Impact of inflammatory bowel disease nurse specialist on quality of the patient journey

I. Arnott, E. Fernandez, K. Kemp, 2013 .

P147 Safety and efficacy of ustekinumab for Crohn’s disease (CD): the cross pennine experience

Rachael C. Walker, C. Stansfield, C. Selinger, 2021, Posters.

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Sarah F. Griffee, Susan M. Kilroy, Philip Smith, 2022, The Lancet Gastroenterology & Hepatology.

service priorities: guidance for nurses Aligning oral mesalazine treatment to health

K. Kemp, Mark Sephton, 2013 .

Transforming Congregational Conflict: An Integrated Framework for Understanding and Addressing conflict in Christian Faith Communities

K. Kemp, 2010 .

An exploration of the follow-up up needs of patients with inflammatory bowel disease.

K. Lovell, S. Campbell, J. Griffiths, 2013, Journal of Crohn's & colitis.

Preventing perinatal depression in low-income home visiting clients: a randomized controlled trial.

T. Mendelson, S. Tandon, Julie A. Leis, 2011, Journal of consulting and clinical psychology.

Six-Month Outcomes from a Randomized Controlled Trial to Prevent Perinatal Depression in Low-Income Home Visiting Clients

T. Mendelson, S. Tandon, Julie A. Leis, 2014, Maternal and Child Health Journal.

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Susan M. Kilroy, C. Lees, T. Ahmad, 2022, Nature Communications.

Using a geographic information system to enhance patient access to point-of-care diagnostics in a limited-resource setting

William J. Ferguson, G. Kost, W. Ferguson, 2016, International Journal of Health Geographics.

Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn’s Disease or Ulcerative Colitis

L. Moortgat, L. Dibley, A. Sturm, 2018, Journal of Crohn's & colitis.

Understanding the health and social care needs of people living with IBD: a meta-synthesis of the evidence.

K. Lovell, J. Griffiths, K. Kemp, 2012, World journal of gastroenterology.

Patient choice in administering anti-TNF for severe, active Crohn's disease in adults

S. Campbell, K. Kemp, 2009 .

An evaluation study of a pilot group education programme for inflammatory bowel disease

K. Kemp, Mark Sephton, V. Ridgway, 2015, Frontline Gastroenterology.

Assessing quality of life in Crohn’s disease: development and validation of the Crohn’s Life Impact Questionnaire (CLIQ)

S. McKenna, J. Wilburn, S. Campbell, 2015, Quality of Life Research.

N-ECCO survey results of nursing practice in caring for patients with Crohn's disease or ulcerative colitis in Europe.

Karen Kemp, C. J. van der Woude, C Janneke van der Woude, 2014, Journal of Crohn's & colitis.

P042 - 2 year follow up of adalimumab therapy in patients with Crohn's disease

A. Makin, S. Campbell, M. Dibb, 2009 .

P182 - Patient perceptions of home biologic therapy – adalimumab

A. Makin, S. Campbell, K. Kemp, 2009 .

Inflammatory Bowel Disease in the South Asian Population of Northwest England

W. Newman, A. Makin, S. I. Jamallulail, 2008 .

A qualitative study of the impact of Crohn's disease from a patient's perspective

S. McKenna, J. Wilburn, K. Kemp, 2016, Frontline Gastroenterology.

OC-005 An exploration of the health and social needs of people living with inflammatory bowel disease: a metasynthesis

K. Lovell, J. Griffiths, K. Kemp, 2012, Gut.

OC-001 Inflammatory bowel disease nursing: results of an audit exploring the roles, responsibilities and activity of nurses with specialist/advanced roles within inflammatory bowel disease

K. Holbrook, K. Kemp, V. Garrick, 2012, Gut.

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

A. de Silvestri, C. Stansfield, C. Selinger, 2021, Alimentary pharmacology & therapeutics.

P525 Effectiveness and safety of vedolizumab in IBD patients: a multicentre experience of "real world data" from the UK.

C. Stansfield, C. Selinger, P. Hamlin, 2017, Journal of Crohn's & colitis.

A competency framework for inflammatory bowel disease nurses.

K. Kemp, Mark Sephton, 2013, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

Scoping review with textual narrative synthesis of the literature reporting stress and burn-out in specialist nurses: making the case for inflammatory bowel disease nurse specialists

L. Dibley, K. Kemp, L. Younge, 2022, BMJ open gastroenterology.